These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35754132)

  • 1. Successful desensitization protocol for a patient with fludarabine anaphylaxis during hematopoietic transplantation.
    Xu M; AlRiyami L; Rao H; Hook R; Wall DA; Schechter T; Grunebaum E
    Pediatr Allergy Immunol; 2022 Jun; 33(6):e13789. PubMed ID: 35754132
    [No Abstract]   [Full Text] [Related]  

  • 2. Protocol for Desensitization to Trastuzumab in a Patient With Anaphylaxis and Stage IV Breast Cancer: A Case Report.
    de Lira-Quezada CE; Villarreal-González RV; González-Díaz SN; Acuña-Ortega N
    J Investig Allergol Clin Immunol; 2020; 30(5):376-377. PubMed ID: 32376514
    [No Abstract]   [Full Text] [Related]  

  • 3. Laronidase desensitization during stem cell transplant in a child with Hurler syndrome.
    Rosenberg J; Jhaveri P; Kelbel T
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):377-8. PubMed ID: 26916445
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful desensitization of a patient with Fabry disease with agalsidase beta (Fabrazyme) anaphylaxis after omalizumab pretreatment.
    DuBuske I; Schmidlin K; Bernstein JA
    Ann Allergy Asthma Immunol; 2021 Jan; 126(1):96-98. PubMed ID: 32866621
    [No Abstract]   [Full Text] [Related]  

  • 5. Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization.
    González-de-Olano D; Morgado JM; Juárez-Guerrero R; Sánchez-Muñoz L; Letellez-Fernández J; Malón-Giménez D; Castells MC
    J Allergy Clin Immunol Pract; 2016; 4(2):338-40. PubMed ID: 26725157
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization.
    Hutten EM; Roeloffzen WW; Lambeck AJ; van den Born-Bondt T; Oude Elberink HN; van de Ven AAJ
    J Investig Allergol Clin Immunol; 2024 Jun; 34(3):214-216. PubMed ID: 38888584
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful rapid oral clindamycin desensitization in a pediatric patient.
    Esty B; Minnicozzi S; Chu EC; Broyles AD; Yee CSK
    J Allergy Clin Immunol Pract; 2018; 6(6):2141-2142. PubMed ID: 29655773
    [No Abstract]   [Full Text] [Related]  

  • 8. An unusual case of immediate hypersensitivity reaction to a common medication.
    Dass K; Bose S; Ditto AM
    Ann Allergy Asthma Immunol; 2016 Jul; 117(1):14-6. PubMed ID: 27234937
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness of Omalizumab in Rapid Drug Desensitization in Patients With Severe Anaphylaxis Induced by Carboplatin: Open Questions.
    Sánchez-Morillas L; Casado Herráez A; Rubio-Perez M; Robledo Echarren T; González Gutiérrez ML; Cimarra M; Vázquez Cortés S; Cerecedo I; Fernández-Rivas M
    J Investig Allergol Clin Immunol; 2020; 30(4):298-300. PubMed ID: 32101175
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful desensitization in a pediatric patient with acetazolamide allergy.
    Carlisle A; Kennedy JL; Chervinskiy S; Jones SM; Pesek RD
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):508-509. PubMed ID: 29966705
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective desensitization to imiglucerase in a patient with type I Gaucher disease.
    Peroni DG; Pescollderungg L; Piacentini GL; Cassar W; Boner AL
    J Pediatr; 2009 Dec; 155(6):940-1. PubMed ID: 19914435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for Desensitization to Atezolizumab and Bevacizumab After Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma.
    Gonzalez-Diaz SN; Villarreal-Gonzalez RV; De Lira-Quezada CE; Rocha-Silva GK; Oyervides-Juarez VM; Vidal-Gutierrez O
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):265-267. PubMed ID: 32856592
    [No Abstract]   [Full Text] [Related]  

  • 13. The Who, What, Where, When, Why, and How of Drug Desensitization.
    Yang BC; Castells MC
    Immunol Allergy Clin North Am; 2022 May; 42(2):403-420. PubMed ID: 35469626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab may facilitate drug desensitization in patients failing standard protocols.
    Gemici Karaaslan HB; Karabag Yilmaz E; Gulmez R; Canpolat N; Kiykim A; Cokugras HC
    Pediatr Allergy Immunol; 2022 May; 33(5):e13783. PubMed ID: 35616895
    [No Abstract]   [Full Text] [Related]  

  • 15. Vancomycin anaphylaxis and successful desensitization.
    Anne' S; Middleton E; Reisman RE
    Ann Allergy; 1994 Nov; 73(5):402-4. PubMed ID: 7978531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Infusion of Obinutuzumab by Desensitization: A Case of Anaphylactic Shock During Desensitization.
    Kim KW; Chung S; Lee SY; Yoon SS; Kang HR
    J Investig Allergol Clin Immunol; 2020; 30(6):457-459. PubMed ID: 32376522
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful desensitization of elosulfase alfa-induced anaphylaxis in a pediatric patient with Morquio syndrome.
    Guvenir H; Dibek Misirlioglu E; Capanoglu M; Buyuktiryaki B; Unal O; Toyran M; Kocabas CN
    J Allergy Clin Immunol Pract; 2017; 5(4):1156-1157. PubMed ID: 28689831
    [No Abstract]   [Full Text] [Related]  

  • 18. Anaphylactic Shock due to Isatuximab and Successful Desensitization.
    Torres Górriz MC; Borrás Cuartero J; Germán Sánchez A; Pesántez Méndez CG; Stein Coronado CI; Fernández-Delgado M; Beltrán Agost S; Enrique E
    J Investig Allergol Clin Immunol; 2024 Jun; 34(3):200-202. PubMed ID: 37812194
    [No Abstract]   [Full Text] [Related]  

  • 19. Anaphylaxis after Elosulfase A infusion: Omalizumab as coadjuvant for enzyme replacement therapy desensitization.
    Arroabarren E; Aznal E; Anda M; Sanchez-Valverde F
    Pediatr Allergy Immunol; 2019 Jun; 30(4):491-494. PubMed ID: 30817035
    [No Abstract]   [Full Text] [Related]  

  • 20. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
    Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
    Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.